NCT03013998 | Previously Untreated Acute Mye... more >>loid Leukemia Collapse << | Phase 1
Phase 2 | Recruiting | December 2021 | United States, Arizona
... more >>
Mayo Clinic Arizona
Recruiting
Phoenix, Arizona, United States, 85054
Principal Investigator: Lisa Sproat, MD
United States, California
UCLA Ronald Reagan Medical Center
Recruiting
Los Angeles, California, United States, 90095
Principal Investigator: Gary Schiller, MD
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94143
Principal Investigator: Gabriel Mannis, MD
United States, Colorado
University of Colorado
Recruiting
Denver, Colorado, United States, 80203
Principal Investigator: Dan Pollyea, MD
United States, Florida
Mayo Clinic Florida
Recruiting
Jacksonville, Florida, United States, 32224
Principal Investigator: James Foran, MD
United States, Georgia
Emory University
Recruiting
Atlanta, Georgia, United States, 30308
Principal Investigator: William Blum, MD
United States, Illinois
University of Chicago
Recruiting
Chicago, Illinois, United States, 60637
Principal Investigator: Wendy Stock, MD
United States, Maryland
University of Maryland Medical Center
Recruiting
Baltimore, Maryland, United States, 21201
Principal Investigator: Maria Baer, MD
United States, New York
Memorial Sloan Kettering Cancer Center
Recruiting
New York, New York, United States, 10065
Principal Investigator: Eytan M Stein, MD
United States, Ohio
Ohio State University
Recruiting
Columbus, Ohio, United States, 43210
Principal Investigator: John C Byrd, MD
Principal Investigator: Alice Mims, MD
Principal Investigator: Alison R Walker, MD, MPH
United States, Oregon
Oregon Health & Science University
Recruiting
Portland, Oregon, United States, 97239
Principal Investigator: Uma Borate, MD
United States, Texas
University of Texas Southwestern
Recruiting
Dallas, Texas, United States, 75390
Principal Investigator: Prapti Patel, MD
United States, Utah
Huntsman Cancer Institute, University of Utah
Recruiting
Salt Lake City, Utah, United States, 84112
Principal Investigator: Michael Deininger, MD, PhD Collapse << |
NCT03564821 | IDH1 Mutation Myeloid Neoplasm... more >>s Collapse << | Phase 1 | Not yet recruiting | July 31, 2024 | United States, Massachusetts
... more >>
Massachusetts General Hospital
Not yet recruiting
Boston, Massachusetts, United States, 02214
Contact: Amir T Fathi, MD 617-724-4000 afathi@partners.org
Principal Investigator: Amir T Fathi, MD Collapse << |
NCT02831972 | Healthy | Phase 1 | Completed | - | United States, Arizona
... more >>
Tempe, Arizona, United States, 85283 Collapse << |
NCT03471260 | Other Diseases of Blood and Bl... more >>ood-forming Organs
Advanced Hematologic Malignancies
Acute Myeloid Leukemia Collapse << | Phase 1
Phase 2 | Recruiting | September 2019 | United States, Texas
... more >>
University of Texas MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contact cdinardo@mdanderson.org Collapse << |
NCT02677922 | Leukemia, Myeloid, Acute | Phase 1
Phase 2 | Active, not recruiting | January 28, 2019 | - |
NCT02579707 | Healthy | Phase 1 | Completed | - | United States, Wisconsin
... more >>
Research Site
Madison, Wisconsin, United States, 53704 Collapse << |
NCT02632708 | Newly Diagnosed Acute Myeloid ... more >>Leukemia (AML)
Untreated AML
AML Arising From Myelodysplastic Syndrome (MDS)
AML Arising From Antecedent Hematologic Disorder (AHD)
AML Arising After Exposure to Genotoxic Injury Collapse << | Phase 1 | Active, not recruiting | July 2020 | United States, California
... more >>
Duarte, California, United States, 91010
Los Angeles, California, United States, 90095
United States, Colorado
Aurora, Colorado, United States, 80045
United States, Illinois
Chicago, Illinois, United States, 60637
United States, Maryland
Baltimore, Maryland, United States, 21287
United States, Massachusetts
Boston, Massachusetts, United States, 02215
United States, New Jersey
Hackensack, New Jersey, United States, 07601
United States, New York
New York, New York, United States, 10065
United States, Ohio
Columbus, Ohio, United States, 43210
United States, Tennessee
Nashville, Tennessee, United States, 37232
United States, Texas
Dallas, Texas, United States, 75390
Houston, Texas, United States, 77030
Germany
Ulm, Germany, 89081
Netherlands
Amsterdam, Netherlands, 1081 HV
Rotterdam, Netherlands, 3075 EA Collapse << |
NCT03173248 | Newly Diagnosed Acute Myeloid ... more >>Leukemia (AML)
Untreated AML
AML Arising From Myelodysplastic Syndrome (MDS)
Leukemia, Myeloid, Acute Collapse << | Phase 3 | Recruiting | June 2022 | - |
NCT03245424 | - | - | - | - | - |
NCT02989857 | Advanced Cholangiocarcinoma
... more >> Metastatic Cholangiocarcinoma Collapse << | Phase 3 | Recruiting | August 2020 | - |
NCT02073994 | Cholangiocarcinoma
... more >> Chondrosarcoma
Glioma
Other Advanced Solid Tumors Collapse << | Phase 1 | Active, not recruiting | June 2021 | United States, California
... more >>
Los Angeles, California, United States, 90095
United States, Colorado
Aurora, Colorado, United States, 80045
United States, Florida
Miami, Florida, United States, 33136
United States, Maryland
Baltimore, Maryland, United States, 21218
United States, Massachusetts
Boston, Massachusetts, United States, 02215
United States, New York
New York, New York, United States, 10065
United States, Tennessee
Nashville, Tennessee, United States, 37203
United States, Texas
Dallas, Texas, United States, 75390
Houston, Texas, United States, 77030
San Antonio, Texas, United States, 78229
France
Villejuif, France, 94800 Collapse << |
NCT03503409 | Myelodysplastic Syndromes
... more >> Acute Myeloid Leukemia Collapse << | Phase 2 | Not yet recruiting | December 1, 2023 | - |
NCT02074839 | Relapsed or Refractory Acute M... more >>yeloid Leukemia (AML)
Untreated AML
Other IDH1-mutated Positive Hematologic Malignancies Collapse << | Phase 1 | Active, not recruiting | May 2021 | - |
NCT03071770 | Healthy | Phase 1 | Completed | - | United States, California
... more >>
West Coast Clinical Trial (WCCT)
Cypress, California, United States, 90630 Collapse << |
NCT03343197 | Glioma | Phase 1 | Recruiting | September 1, 2020 | United States, California
... more >>
United States, California
Recruiting
Los Angeles, California, United States, 90024
United States, California
Recruiting
San Francisco, California, United States, 94143
United States, Massachusetts
United States, Massachusetts
Recruiting
Boston, Massachusetts, United States, 02215
United States, New York
United States, New York
Recruiting
New York, New York, United States, 10065
United States, North Carolina
United States, North Carolina
Recruiting
Durham, North Carolina, United States, 27710
United States, Texas
United States, Texas
Recruiting
Dallas, Texas, United States, 75390 Collapse << |
NCT02489513 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin
... more >>
Research Site
Madison, Wisconsin, United States, 53704 Collapse << |
NCT03282513 | Hepatic Impairment | Phase 1 | Completed | - | United States, Colorado
... more >>
DaVita Clinical Research- Colorado
Lakewood, Colorado, United States, 80228
United States, Minnesota
DaVita Clinical Research- Minnesota
Minneapolis, Minnesota, United States, 55404 Collapse << |